SION

NASDAQ · Biotechnology

Sionna Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$47.13

+0.35 (+0.75%)

As of Aug 8, 1:39 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 82%

Hold 2 12%

Sell 1 6%

Price Target

Analyst Price Target -46.8% upside

Low Target $14.18

Average Target $25.06

High Target $26.23

Current Price $47.13

Current
$47.13

Target
$25.06

$14.18 $25.06 avg $26.23

Scenario Analysis

Bear Case

$14.18

-69.9%

Low target

Base Case

$25.06

-46.8%

Avg target

Bull Case

$26.23

+-44.3%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$51.91

-9.2% from high

52-Week Low

$16.48

+186.0% from low

Target vs 52W High

$25.06

-51.7% vs high

Next Earnings Report

Aug 17, 2026

until earnings

EPS Est: $-0.66

Earnings in 8 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%